HEAL IDG Supplement Opportunity
A new quick turn-around opportunity for administrative supplements has been published by the Helping to End Addiction Long-term SM Initiative, or NIH HEAL Initiative SM in coordination with the Illuminating the Druggable Genome (IDG) program. As part of the HEAL Initiative, NCATS and other participating Institutes and Centers (ICs) are inviting investigators with relevant active research project grants and cooperative agreements to submit administrative supplements, according to PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional). Funding is available to support projects to identify and validate new pain and opioid use disorder (OUD) targets from within the understudied Druggable Genome.
For the complete text and/or questions about this opportunity, contact information and details can be found at:https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-008.html
Please direct all inquiries to:
Karlie Sharma, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Request for Applications: Nonhuman Primate Feasability Pilot Studies
We are pleased to offer two awards in 2020, each with a budget cap of $20,000. We will consider scientific requests that translate preclinical or clinical observations, and encourage non-destructive studies. One award aims to target proposals that investigate blood pressure, hypertension, or vascular biology. A second award is open to all categories of research.
Krupp Endowed Fund (KEF)
On behalf of the UC San Diego Center for Integrative Research (CIR) Research Executive Committee of the Krupp Endowed Fund (KEF), we are pleased to announce that we are accepting applications for funding. In order to apply, please visit KEF.ucsd.edu and download the Request for Applications (RFA) for further instructions, timeline, and details.
Note that the deadline for receipt of Letters of Intent has been extended until 11:59 pm on March 15, 2020. We anticipate a significant increase in the number of awards we will be able to make during this funding cycle, particularly smaller KS grants (described in RFA).
The primary aim of the KEF is to support research that examines the benefits of natural complementary and alternative medicine and integrative medicine approaches that show the promise of bettering human health for the largest number of people, at the lowest cost, without the use of prescription drugs or surgery. The primary objective of the KEF is to support innovative clinical research in the fields of diet; medicinal food and herbs; food derived macro- and micronutrients (which include vitamins and minerals); and homeopathy.
To be eligible to apply for a grant, an applicant must be a UC San Diego employee and a member of the KEF. Non-UC San Diego members may be co-investigators on KEF proposals. Please visit KEF.ucsd.edu for more details.
Harrington Scholar-Inovator Award – Open Now!
Harrington Discovery Institute (HDI) invites you to submit an LOI for the 2021 Harrington Scholar-Innovator Award. This grant supports all disease areas and is designed to advance your promising drug discovery research towards the clinic. In addition to grant funding, HDI provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.
- M.D. required for eligibility. Open to physician-scientists in the U.S. and Canada.
- Letters of Intent (LOI) due: March 27, 2020.
- Full applications due May 15, 2020 for those invited to submit.
Attached are additional information on the Scholar-Innovator Award:
- One-page overview
- Frequently Asked Questions
- Grant application outline
- Submission instructions
Check out these short videos from Harrington Scholar-Innovators.
To submit an LOI online, go to HDI's grant system and create an account.
Questions? Please email HDIQuestions@HarringtonDiscovery.org.
Notification of Upcoming 2020 UC Research in OptumLabs Data Warehouse Call for Proposals (CFP)
As part of the strategic relationship between UC and OptumLabs, OptumLabs will provide up to seven UC researchers with OptumLabs-funded access to its database of de-identified, linked clinical and administrative claims information (terms and conditions apply).
The credit includes data access for one research project and OptumLabs technology infrastructure with standard configuration for two users. Each project is scheduled to last one year after data access is granted (unless an extension deadline is filed and approved).
OptumLabs is an open, collaborative center for research and innovation focused on improving patient care and value. The comprehensive real-world data with nearly 200 million de-identified lives across claims and clinical information contains a rich, linked dataset, which can be used to conduct broad or narrow investigations on populations and unique subsets within them.
We will be soliciting proposals for research ideas that leverage the OptumLabs data. Examples of research projects using OptumLabs data include: variation in care, utilization, safety and efficacy, predictive modeling, policy and incentives, outcomes, methods, literature review, health economics, guidelines/quality of care, epidemiology, disparities, delivery of care, and comparative effectiveness.
Download flyer for more information
OptumLabs and UC Health
The University of California and UnitedHealth Group have formed a strategic partnership to collaborate and work strategically to improve healthcare. One aspect of the strategic relationship is the research collaboration with OptumLabs, a data-driven research and discovery center, with a focus on working with OptumLabs data sets, analytical tools and collaborations to advance clinical research and translation. OptumLabs is an open, collaborative center for research and innovation focused on improving patient care and value. Its comprehensive real-world data with over 160 million de-identified lives across claims and clinical information contains a rich, linked dataset that can be used to conduct broad or narrow investigations on populations and unique subsets within them. More information